Studies on the metabolism of DHEA in rats and mice

Dehydroepiandrosterone (DHEA): Biochemical, Physiological and Clinical Aspects

Volumn , Issue , 2011, Pages 343-362

  Hobe, Gerhard ^a   Hillesheim, Hans Georg ^a   Schön, Renate ^a   Undisz, Katrin ^a   Valentin, Ulrike ^a   Reddersen, Gudrun ^b   Ritter, Petra ^b   Bannasch, Peter ^c   Mayer, Doris ^c  

^a HANS KNÖLL INSTITUTE   (Germany)

^b EnTec GmbH   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884574577     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (39)

1. Schwartz, A.G. and Tannen, R.H. (1981). Inhibition of 7, 12-dimethyl-benz(a(anthracene-and urethan-induced lung tumor formation in A/J mice by longterm treatment with dehydroepiandrosterone. Carcinogenesis 2, 1335-1337
2. Schwartz, A.G., Pashko, L. and Whitcomb, J.M. (1986). Inhibition of tumor development by dehydroepiandrosterone and related steroids. Toxicol. Pathol. 14, 357-362
3. Hayashi, F., Tamura, H., Yamada, J., Kasai, H. and Suga, T. (1994). Characteristics of hepatocarcinogenesis caused by dehydroepiandrosterone., a peroxisome proliferator in male F-344 rats. Carcinogenesis 15, 2215-2219
4. Rao, M.S., Subbaro, V., Yeldani, A.V. and Reddy, J.K. (1992). Hepato-carcinogenesis of dehydroepiandrosterone in the rat. Cancer Res. 52, 2977-2979
5. Nyce, J.W., Magee, P.N., Hard, G.C. and Schwartz, A.G. (1984). Inhibition of 1, 2-dimethylhydrazine-induced colon tomorigenesis in Balb/c mice by dehydroepi-androsterone. Carcinogenesis 5, 57-62
6. Loria, R.M., Inge, T.H., Cook, S.S., Szakal, A.K. and Regelson, W. (1988). Protection against acute lethal viral infections with native steroid dehydroepi-androsterone (DHEA). J. Med. Virol. 26/3, 301-314
7. Coleman, D.L., Leiter, F.H. and Schwizer, R.H. (1982). Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 31, 830-833
8. Schwartz, A.G. (1979). Inhibition of spontaneous breast cancer formation in female CH3(AVY/a) mice by long term treatment with dehydroepiandrosterone. Cancer Res. 51, 666-671
9. Hobe, G., Hillesheim, H.G., Schön, R, Ritter, P., Reddersen, G, Mayer, D. and Bannasch, P. (1994). Sex differences in dehydroepiandrosterone (DHEA) metabolism in the rat. In: Advances in Steroid Analysis '93 (Ed. S. Görög). Akademiai Kiädo, Budapest, 383-390
10. Hamilton, S.R., Gordon, G.B., Floyd, J. and Golightly, S. (1991). Evaluation of dehydroepiandrosterone for chemoprotection against tomorigenesis in premalignant colonic epithelium of male F-344 rats. Cancer Res. 51, 476-480
11. Wichmann, U.G., Wichmann, W. and Krause, W. (1984). Serum levels of testosterone precursors, testosterone and estradiol in 10 animal species. Exper. Clin. Endocrinol. 83, 283-290
12. Baulieu, E.E. (1989). Dehydroepiandrosterone (DHEA): Important or very important? The last 30 years saga. Symposium Pharmaco-Clinique Roussel-Uclaf, Paris, 9-11
13. Freymann, E. and Hubl, W. (1991). Determination of dehydroepiandrosterone sulfate in serum by an enzyme immunoassay on microtitre plates. In: Advances in Steroid Analysis '90 (Ed. S. Görög). Akademiai Kiädo, Budapest, 97-101
14. Klotz, U. (1979). Klinische Pharmakokinetik. Gustav Fischer Verlag, Stuttgart, 100
15. Burstein, S. and Lieberman, S. (1958). Hydrolysis of ketosteroid hydrogen sulfates by solvolysis procedures. J.Biol.Chem.233, 331-335
16. Seymour-Munn, K. and Adams, J. (1981). Estrogenic effects of 5-androstene-3β, 17β-diol at physiological concentrations and its possible implications in the etiology of breast cancer. Cancer Res. 41, 4720-4725
17. Loria, R.M. and Padgett, D.A. (1992). Androstenediol regulates systemic resistance against lethal infections in mice. Arch. Virol. 127, 103-115
18. Freudenthal, R.I., Cook, C.E., Rosenfield, R. and Wall, M.E. (1971). The effect of different incubation systems on the in vitro metabolism of norethynodrel. J. Steroid Biochem 2, 77-82
19. Bradlow, H.L. (1968). Extraction of steroid conjugates with a neutral resin. Steroids 11, 265-275
20. Kalimi, M. and Regelson W. (1988). Physicochemical characterization of [3H] DHEA binding in rat liver. Biochem. Biophys. Res. Commun. 156, 22-29
21. Meikle, A.W., Dorchuk, R.W., Araneo, B.A., Stringham, J.D., Evans, D.G., Spruance, S.L. and Daynes, R.A. (1992). The presence of a dehydroepi-androsterone-specific receptor binding complex in murine T cells. J. Steroid Biochem. Mol. Biol. 42, 293-304
22. Yamada, Y, Sugiyama, H., Sakuma, M. and Suga, T. (1994). Specific binding of dehydroepiandrosterone sulfate to rat liver cytosol: a possible association with peroxisomal enzyme induction. Biochim. Biophys. Acta 1224, 139-146
23. Mohan, P.F. and Cleary, M.P. (1992). Studies on the nuclear binding of dehydro-epiandrosterone in hepatocytes. Steroids 57, 244-247
24. Armanini, D., Strasser, T. and Weber, P.C. (1985). Parallel determination of glucocorticoid receptors in human mononuclear and polymorphonuclear leucocytes after Percoll separation. J. Endocrinol. Invest. 8, 45-47
25. Blauer, E.S., Poth, M., Rogers, W.H. and Berton, E.W. (1991). Dehydroepiandro-sterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 129, 3174-3179
26. Kalimi, M., Shafagoj, Y., Loria, R., Padgett, D. and Regelson, W. (1994). Antiglucocorticoid effects of dehydroepiandrosterone (DHEA). Mol. Cell. Biochem. 131, 99-104
27. Browne, E.S., Wright, B.E., Porter, J.R. and Svec, F. (1992). Dehydroepiandro-sterone: Antiglucocorticoid action in mice. Am. J. Med. Sei. 303, 366-371
28. Feher, T., Bodrogi, L., Feher, K.G., Potrescin, E. and Kölcsey, I.S. (1977). Free and solvolysable dehydroepiandrosterone and androsterone in mammals under physiological conditions and following administration of dehydroepiandrosterone. Acta Endocrinol. 85, 126-133
29. Schriefers, H., Ghraf, R., Hoff, H.G. and Ockenfels, H. (1971). Einfluβ von Alter und Geschlecht auf die Entwicklung und Differenzierung der Aktivitätsmuster von Enzymen des Steroidhormon-Stoffwechsels in der Leber von Ratten zweier verschiedener Tierstämme. Hoppe-Seylef s Z. Physiol. Chem. 352, 1363-1371
30. Casey, M.L., Shackleton, C.H.L. and MacDonald, P.C. (1988). Dehydroepi-androsterone therapeutics: acetylation of DHA in mouse liver. J. Steroid Biochem. 30, 149-154
31. Starka, L. and Kutova, J. (1962). 7-Hydroxylation of dehydroepiandrosterone by rat liver homogenate. Biochim. Biophys. Acta 56, 76-82
32. Colas, A. (1962). The 16(-hydroxylation of dehydroepiandrosterone (3β-hydroxy-androst-5-en-17-one) by rat liver slices. Biochem J. 82, 390-394
33. Rose, K.A., Stapleton, G., Dott, K, Kieny, M.P., Best, R, Schwarz, M, Rüssel, D.W., Bjöorghem, I., Seckl, J. and Lathe, R. (1997). Cyp 7b, a novel brain cytochrome p450, catalyzes the synthesis of neurosteroids 7ahydroxy-dehydro-epiandrosterone and 7a-hydroxy-pregnenolone. Proc. Natl. Acad. Sei. USA 94, 1925-1930
34. Doostzadeh, J., Cotillon, A.C., Benalycherif, A. and Morfin R. (1998). Inhibition studies of dehydroepiandrosterone 7a-and 7β-hydroxylation in mouse liver microsomes. Steroids 63, 608-614
35. Morfin, R. and Courchay, G. (1994). Pregnenolone and dehydroepiandrosterone as precursors of native 7-hydroxylated metabolites which increase the immune response in mice. J. Steroid Biochem. Mol. Biol. 50, 91-100
36. Loria, R.M. and Padgett, D.A. (1994). In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol and androstenetriol. J. Immunol. 153, 1544-1552
37. Crudo, D. (1989). Downregulation of glucocorticoid receptors by dehydroepi-androsterone. 71th Ann. Meet. Endocr. Soc., Seattle, WA, p. 236 (abstract)
38. Bernton, E., Dang, T., Chandra, R. and Dave, J. (1992). DHEA treatment down-regulates liver and splenocyte glucocorticoid receptors in mice. 74th Ann. Meet. Endocr. Soc., San Antonio, TX, p. 152
39. Browne, E.S., Porter, J.R., Correra, G., Abadie, J. and Svec, F. (1993). Dehydro-epiandrosterone regulation of the hepatic glucocorticoid receptor in the Zucker rat. The obesity research program. J. Steroid. Biochem. Mol. Biol. 45, 123-130